These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38030336)

  • 1. Subcutaneous Implantable Cardioverter Defibrillators in Pediatrics and Congenital Heart Disease.
    Kohli U; von Alvensleben J; Srinivasan C
    Card Electrophysiol Clin; 2023 Dec; 15(4S):e1-e16. PubMed ID: 38030336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis.
    Araújo CS; Silva CLB; da Silva Menezes Júnior A; Barbosa VA; de Almeida Laranjeira T; Fernandes JF; Gonçalves LC; Silva AMC
    Curr Cardiol Rev; 2022; 18(3):e081221198647. PubMed ID: 34879809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transvenous and non-transvenous implantable cardioverter-defibrillators in children, adolescents, and adults with congenital heart disease: who is at risk for appropriate and inappropriate shocks?
    Krause U; Müller MJ; Wilberg Y; Pietzka M; Backhoff D; Ruschewski W; Paul T
    Europace; 2019 Jan; 21(1):106-113. PubMed ID: 30339209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillators in congenital heart disease.
    Mondésert B; Khairy P
    Curr Opin Cardiol; 2014 Jan; 29(1):45-52. PubMed ID: 24284978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Adults With Congenital Heart Disease.
    Moore JP; Mondésert B; Lloyd MS; Cook SC; Zaidi AN; Pass RH; John AS; Fish FA; Shannon KM; Aboulhosn JA; Khairy P;
    Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous implantable cardioverter defibrillator: Can it overtake its transvenous counterpart.
    Savarimuthu S; Roy S; Obeidat M; Harky A
    Pacing Clin Electrophysiol; 2021 Aug; 44(8):1413-1420. PubMed ID: 33878197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous Implantable Cardioverter-Defibrillators in Patients With Congenital Heart Disease.
    Waldmann V; Marquié C; Bessière F; Perrot D; Anselme F; Badenco N; Barra S; Bertaux G; Blangy H; Bordachar P; Boveda S; Chauvin M; Clémenty N; Clerici G; Combes N; Defaye P; Deharo JC; Durand P; Duthoit G; Eschalier R; Fauchier L; Garcia R; Geoffroy O; Gitenay E; Gourraud JB; Guenancia C; Iserin L; Jacon P; Jesel-Morel L; Kerkouri F; Klug D; Koutbi L; Labombarda F; Ladouceur M; Laurent G; Leclercq C; Maille B; Maltret A; Massoulié G; Mondoly P; Ninni S; Ollitrault P; Pasquié JL; Pierre B; Pujadas P; Champ-Rigot L; Sacher F; Sadoul N; Schatz A; Winum P; Milliez PU; Probst V; Marijon E
    J Am Coll Cardiol; 2023 Aug; 82(7):590-599. PubMed ID: 37558371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous Implantable Cardioverter-Defibrillators in Pediatrics and Congenital Heart Disease: A Pediatric and Congenital Electrophysiology Society Multicenter Review.
    von Alvensleben JC; Dechert B; Bradley DJ; Fish FA; Moore JP; Pilcher TA; Escudero C; Ceresnak SR; Kwok SY; Balaji S; Aziz PF; Papagiannis J; Cortez D; Garnreiter J; Kean A; Schäfer M; Collins KK
    JACC Clin Electrophysiol; 2020 Dec; 6(14):1752-1761. PubMed ID: 33357571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of non-transvenous cardioverter defibrillators in infants and young children.
    Müller MJ; Dieks JK; Backhoff D; Schneider HE; Ruschewski W; Tirilomis T; Paul T; Krause U
    J Interv Card Electrophysiol; 2019 Mar; 54(2):151-159. PubMed ID: 30255451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions.
    Verma N; Rhyner J; Knight BP
    Expert Rev Cardiovasc Ther; 2015; 13(9):989-99. PubMed ID: 26308601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electromagnetic interference from left ventricular assist devices in patients with subcutaneous implantable cardioverter-defibrillators.
    Ishida Y; Payne JE; Field ME; Gold MR
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1195-1201. PubMed ID: 32128931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-center experience with implantable cardioverter-defibrillators in adults with complex congenital heart disease.
    Khanna AD; Warnes CA; Phillips SD; Lin G; Brady PA
    Am J Cardiol; 2011 Sep; 108(5):729-34. PubMed ID: 21684513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eligibility for subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease.
    Zormpas C; Silber-Peest AS; Eiringhaus J; Hillmann HAK; Hohmann S; Müller-Leisse J; Westhoff-Bleck M; Veltmann C; Duncker D
    ESC Heart Fail; 2021 Apr; 8(2):1502-1508. PubMed ID: 33538124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes.
    Santharam S; Hudsmith L; Thorne S; Clift P; Marshall H; De Bono J
    Europace; 2017 Mar; 19(3):407-413. PubMed ID: 27234868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillator insertion in congenital heart disease without transvenous access to the heart.
    Nery PB; Green MS; Khairy P; Alhebaishi Y; Hendry P; Birnie DH
    Can J Cardiol; 2013 Feb; 29(2):254.e1-3. PubMed ID: 22749646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous versus transvenous implantable cardioverter defibrillators in children and young adults: A meta-analysis.
    Vetta G; Parlavecchio A; Magnocavallo M; Valente D; Caminiti R; Polselli M; Vetta F; Cirone D; Cauti FM; Crea P; Rossi P; Chierchia GB; Bianchi S; de Asmundis C; Natale A; Della Rocca DG
    Pacing Clin Electrophysiol; 2022 Dec; 45(12):1409-1414. PubMed ID: 36214206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillators in congenital heart disease.
    Chubb H; Rosenthal E
    Herzschrittmacherther Elektrophysiol; 2016 Jun; 27(2):95-103. PubMed ID: 27250725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator.
    Gasperetti A; Schiavone M; Vogler J; Laredo M; Fastenrath F; Palmisano P; Ziacchi M; Angeletti A; Mitacchione G; Kaiser L; Compagnucci P; Breitenstein A; Arosio R; Vitali F; De Bonis S; Picarelli F; Casella M; Santini L; Pignalberi C; Lavalle C; Pisanò E; Ricciardi D; Calò L; Curnis A; Bertini M; Gulletta S; Dello Russo A; Badenco N; Tondo C; Kuschyk J; Tilz R; Forleo GB; Biffi M
    Heart Rhythm; 2022 Dec; 19(12):1958-1964. PubMed ID: 35781042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.